Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Tetzlaff

Showing results (161-170 of 224) with videos related to

Pageof 23
Sort By:
Journal for Immunotherapy of Cancer|November 18, 2020
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapyYong Qin, Kathryn Bollin, Mariana Petaccia de Macedo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Likun Li, Guang Yang, et al.
Journal of Cutaneous Pathology|March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutationsDavid L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
The Journal of Investigative Dermatology|March 5, 2023
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in MelanomaSharmeen Chagani, Mariana P De Macedo, Fernando Carapeto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic targetGuo Chen, Nitin Chakravarti, Kimberly Aardalen, et al.
Human Pathology|June 11, 2015
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced MelanomaMichael T Tetzlaff, Penvadee Pattanaprichakul, Jennifer Wargo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular DensityPhyu P Aung, Edwin Roger Parra, Souptik Barua, et al.
Cancer|December 3, 2016
Clinicopathological features and clinical outcomes associated with TP53 and BRAF<sup>N</sup><sup>on-</sup><sup>V</sup><sup>600</sup> mutations in cutaneous melanoma patientsDae Won Kim, Lauren E Haydu, Aron Y Joon, et al.
Cancer Medicine|October 5, 2020
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarkerGrant M Fischer, Fernando C L Carapeto, Aron Y Joon, et al.
Cancer Immunology Research|May 3, 2019
Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast CancerSangeetha M Reddy, Alexandre Reuben, Souptik Barua, et al.
Pageof 23

Showing results (161-170 of 224) with videos related to

Sort By:
Pageof 23
Journal for Immunotherapy of Cancer|November 18, 2020
Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapyYong Qin, Kathryn Bollin, Mariana Petaccia de Macedo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2019
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate CancerBo Liu, Likun Li, Guang Yang, et al.
Journal of Cutaneous Pathology|March 11, 2015
Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutationsDavid L Stockman, Jonathan L Curry, Carlos A Torres-Cabala, et al.
The Journal of Investigative Dermatology|March 5, 2023
Multiplatform Analysis of Intratumoral PTEN Heterogeneity in MelanomaSharmeen Chagani, Mariana P De Macedo, Fernando Carapeto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic targetGuo Chen, Nitin Chakravarti, Kimberly Aardalen, et al.
Human Pathology|June 11, 2015
Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced MelanomaMichael T Tetzlaff, Penvadee Pattanaprichakul, Jennifer Wargo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular DensityPhyu P Aung, Edwin Roger Parra, Souptik Barua, et al.
Cancer|December 3, 2016
Clinicopathological features and clinical outcomes associated with TP53 and BRAF<sup>N</sup><sup>on-</sup><sup>V</sup><sup>600</sup> mutations in cutaneous melanoma patientsDae Won Kim, Lauren E Haydu, Aron Y Joon, et al.
Cancer Medicine|October 5, 2020
Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarkerGrant M Fischer, Fernando C L Carapeto, Aron Y Joon, et al.
Cancer Immunology Research|May 3, 2019
Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast CancerSangeetha M Reddy, Alexandre Reuben, Souptik Barua, et al.
Pageof 23